Idéal Investisseur
Français English
CAC 40 :
8 157,82 pts
-0.84%


Last updated : 24/04/2026 - 17h35

Stock TRANSGENE (FR0005175080)

Sector : Pharmaceuticals & Biotechnology – Indices : CAC ALL-TRADABLE, CAC ALL SHARES

Price 0,76 €
Daily change 0,00 %
1 week -2,07 %
1 month 0,00 %
1 year +26,17 %

Last update : 24/04/2026 at 17:35:06 – Source: Euronext

Assurance vie

Market summary

As of 24/04/2026, stock TRANSGENE trades at 0,76 € , with a change of 0,00 % , and a market cap of 210 M€.

Open0,00 €
Previous close0,76 €
Volume23 363
Market cap210 M€
P/EN/A
Dividend / shareN/A
Float turnover0,00 %
MarketEuronext PARIS
Eligible PEA, SRD

Price and moving averages

Technical analysis TRANSGENE

50-day moving average0,79 €-4.18 % (below) Pivot0,76 €
Support level0,73 €-3.57 % Resistance level0,79 €+4.36 %
1-month volatility21,20 % Annualised volatility73,44 %
RSI (14d)46 Neutral Stochastic signal (14d)Neutre
ATR (14d)0,02 Low volatility CMF (21d)-0,28 Moderate selling pressure
Bollinger bands (20d) Neutral OBV (21d) Neutral (OBV stable)

Analyst consensus and recommendations

Insufficient data.

Sample rating :
DateAnalyst / BrokerRatingTarget
28/11 Oddo BHF surperformer 1,10 €

Stock history and statistics

IPO dateMar 26, 1998
52-week high1,03 €52-week low0,73 €
All-time high100,83 €All-time low0,53 €
1-year volatility73,44 %Beta-0,39

Financial calendar — TRANSGENE

📅
March 24, 2026 Annual results
📅
April 29, 2026 Résultats Q1
📅
May 13, 2026 Annual General Meeting
📅
September 24, 2026 Résultats du 1er semestre
📅
November 9, 2026 Résultats Q3

Recent news — TRANSGENE

Transgene announces the completion of patient randomization in the Phase 2 segment of its clinical trial evaluating TG4050, a personalized therapeutic…

Transgene and NEC Bio B.V., a subsidiary of NEC Corporation, have entered into a licensing agreement on April 2, 2026, to continue the clinical develo…

French biotech company Transgene raised 144 million euros in December 2025 (105 million through private placement and 39 million through debt conversi…

Latest earnings

Annuels 2025
Revenue 7 M€
+13,5 %
EBITDA -34 M€
Net income -38 M€
-10,5 %
EPS (diluted) -0,26 €
Free cash flow -24 M€
Net debt -110 M€

Analyses on TRANSGENE stock

No analysis has been published on this stock yet.

Frequently asked questions about TRANSGENE stock

What does the recent price action of TRANSGENE stock show?

TRANSGENE stock is currently trading around 0,76 €, flat and down 0,02% over one week.

Is TRANSGENE stock in a support or resistance zone?

Technical levels help place the stock. Support: 0,73 €. Resistance: 0,79 €.

How should the current volatility of TRANSGENE stock be interpreted?

Volatility is around 73,44%.

Ad
Chaque matin
Les signaux techniques du marché,
avant l'ouverture.
CAC 40 · SBF 120 · Signaux · Analystes
🤖
Édition du jour — avant bourse
CAC 40
7 702
-0,87%
SBF 120
5 827
-0,87%
📈 Signaux haussiers
+5,2%
+1,8%
+0,9%
📉 Signaux baissiers
-14%
-5,7%
🔄 Avis analystes
▲ 35 €
▼ 80 €
Inscrivez-vous pour tout voir →
Avant 9h chaque matin
Données Euronext
Analyse automatique IA
BOURSE · Chaque matin
La synthèse bourse,
avant l'ouverture.
Notre moteur analyse chaque nuit le CAC 40 et le SBF 120. Ce qui mérite attention remonte directement dans votre boîte mail. Gratuit.
Avant 9h00 1000+ inscrits 100% gratuit